- Title: Subtitle
- A New Multidimensional Diagnostic Approach for Chronic Obstructive Pulmonary Disease
- Creators
- S.P. BhattE. AbadiK.A. PratteA. AnzuetoS. BodduluriR. CasaburiP J CastaldiM.H. ChoA.P. ComellasD.J. ConradJ.L. CurtisC. DassD.L. DemeoM.T. DransfieldR. San Jose EsteparE.L. FlenaughM.G. ForemanS. FortisM.K. HanC.P. HershN.A. HananiaJ.E. HokansonS.M. HumphriesM. KirbyK.M. KunisakiP.Z. LiD.A. LynchN.R. MacintyreB.J. MakeD.M. ManninoF.J. MartinezC.E. McevoyB.E. MillerM. MollA. NakhmaniJ.D. NewellE.A. ReganJ.M. ReinhardtS.I. RennardH.B. RossiterM.J. StrandE.S. WanC.H. WendtG.E. WestneyC. WilsonR.A.A. WiseK.A. YoungW.-C. TanE.K. SilvermanJ.D. Crapo
- Resource Type
- Abstract
- Publication Details
- American journal of respiratory and critical care medicine, Vol.211(Abstracts), pp.A2857-A2857
- DOI
- 10.1164/ajrccm.2025.211.Abstracts.A2857
- ISSN
- 1073-449X
- eISSN
- 1535-4970
- Publisher
- AMER THORACIC SOC; NEW YORK
- Grant note
- NHLBI: R01 HL151421, U01 HL089897, U01 HL089856 NIH: 75N92023D00011 COPD FoundationAstraZenecaBayer PharmaceuticalsBoehringer IngelheimGenentechGlaxoSmithKlineNovartisPfizerSunovion
This abstract is funded by: This work was supported by NHLBI R01 HL151421 (SPB & AN), NHLBI U01 HL089897 and U01 HL089856, and NIH contract 75N92023D00011. COPDGene is also supported by the COPD Foundation through contributions made to an Industry Advisory Board that has included AstraZeneca, Bayer Pharmaceuticals, Boehringer Ingelheim, Genentech, GlaxoSmithKline, Novartis, Pfizer, and Sunovion. The funders did not have any role in the analyses or presentation of these findings.
- Language
- English
- Date published
- 05/2025
- Academic Unit
- Roy J. Carver Department of Biomedical Engineering; Radiology; Pulmonary, Critical Care, and Occupational Medicine; Psychiatry; ICTS; Internal Medicine
- Record Identifier
- 9984823075102771
Abstract
A New Multidimensional Diagnostic Approach for Chronic Obstructive Pulmonary Disease
American journal of respiratory and critical care medicine, Vol.211(Abstracts), pp.A2857-A2857
05/2025
DOI: 10.1164/ajrccm.2025.211.Abstracts.A2857
Details
Metrics
66 Record Views